# Study of STA-1 Capsule in Patients With Vascular Dementia (Marrow-Sea Deficiency)

> **NCT01475578** · PHASE2 · COMPLETED · sponsor: **Sinphar Pharmaceutical Co., Ltd** · enrollment: 240 (actual)

## Conditions studied

- Vascular Dementia

## Interventions

- **DRUG:** STA-1
- **DRUG:** Ergoloid Mesylates tablet

## Key facts

- **NCT ID:** NCT01475578
- **Lead sponsor:** Sinphar Pharmaceutical Co., Ltd
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-03
- **Primary completion:** 2002-10
- **Final completion:** 2002-10
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2011-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01475578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01475578, "Study of STA-1 Capsule in Patients With Vascular Dementia (Marrow-Sea Deficiency)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01475578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*